The guidance published on the Medicines and Healthcare products Regulatory Agency (MHRA) website is broadly ... and investigational medicinal products, pharmacovigilance procedures and new IT ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

The MHRA has released statistics on its pharmacovigilance inspections ... a serious violation of applicable legislation and guidelines. The most prevalent critical finding was reference safety ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a suite of guidance specifically designed to help medical device manufacturers understand and prepare for the new post ...

A suite of guidance has been published by the UK Medicines and Healthcare products Regulatory Agency (MHRA). This guidance is designed to help medical device manufacturers understand and prepare for ...

The U.K. Medicines and Health Care Products Regulatory Agency has provided guidance on what does and does not constitute a regulated digital mental health technology, but developers should be aware ...

Nursing Times’ new, open access, learning unit will teach nurses when and how to report suspected adverse drug reactions ...

Other harmful reactions to an investigational drug or a pharmaceutical product must be reported in 90 calendar days, as per the latest pharmacovigilance guidance document released by the Drugs ...

The "Global Regulatory Requirements for Drug Safety & Pharmacovigilance Certification Program" training has been added to ResearchAndMarkets.com's offering. This training course is designed to give ...